C. Oberhoff et al., Perioperative development of a thrombogenic risk profile in patients with carcinomas of the breast: a cause of increased thrombosis, EUR J GYN O, 21(6), 2000, pp. 560-568
Within the context of a prospective study we investigated the influence of
malignant and benign breast disease on the coagulation systems both prior t
o and after surgery. In addition we also investigated to what extent indivi
dual risk factors aid the formation of a thrombophiliac risk profile.
Altogether 50 patients with carcinomas of the breast and 12 patients with b
enign breast disease were included in the study. The coagulation investigat
ions took place prior to surgery and on the 1st, 3rd. 7th and 10th day foll
owing the operation.
The results have already revealed that prior to surgery a clear activation
of the haemostasis takes place among patients with a car cinema of the brea
st. When compared to patients with benign breast conditions there was a far
greater plasma level of factor VIII vWF, fibrinogen, thrombin-antithrombin
III complex, D-dimer fibrin degradation products, tissue-type plasminogen
activator and the activity and the antigen of plasminogen activator inhibit
or 1. Also during the postoperative period the malignant tumour was a stimu
lus for additional increased activity of blood coagulation and fibrinolysis
. Individual risk factors such as age, menopausal status, obesity and smoki
ng lead to a thrombogenic risk profile which could provide a possible expla
nation for the observed increased incidence of thrombosis in breast cancer
patients.
For the clinical work then is a need for intensive pre- and postoperative m
onitoring in the cases of patients with malignant tumours including angiolo
gical examinations, intensive physiotherapy and a risk-adapted prophylactic
anticoagulation.